Leading-edge products that will improve your results.
Research, Development and Innovation (R&D&i) extensive programme.
Seeking efficency and offering alternatives to traditional solutions.
Succesful technology licensing and meaningful worldwide collaborations.
Research and Diagnostic solutions since 2001
As a leading provider of technologies, tools, and services for bioscience and biopharmaceutical manufacturing, we offer a wide range of assays, kits and solutions for Flow Cytometry.
Unlocking the Potential of Exosomes
In 2017 Immunostep R&D team recognized the great potential of exosomes and since then we have been working on the development of a method for detecting, isolating and quantifying extracellular vesicles which are present in fluid samples.
Improving SARS-CoV-2 Serology Testing Performance
As a response to SARs-CoV-2 global emergency we developed a product line in order to improve serological testing performance and help building clinical investigation around Covid-19 disease.
We find the most innovative technology and use them to build adaptative clinical products to diagnose and treat diseases, and we work to achieve our goals under a strict system of values:
We seek always to be at the leading-edge of technology in research areas of development, and in order to achieve that goal, we work under an extensive R&D program headed by a brilliant team of Flow Cytometry experts.
Immunostep strongly supports the renewal of investment in science and technology to support the development of the scientific community and its research efforts on a global scale.
Reinforcing our commitment to offering only the highest-quality products, Immunostep operates a Quality Management System based on the ISO 13485:2018 standard, which sets out the international standards for the manufacture of medical devices and reagents.
The social well-being of our employees, suppliers and local communities is among our objectives as a socially responsible company. We assess the environmental and social impact of all the projects in which we invest and collaborate with our customers to reach international best practice agreements.
Contact
For any information required, please use the form below and we will contact you shortly.
